BPC
TXG icon

Banque Pictet & Cie’s 10x Genomics TXG Stock Holding History

Banque Pictet & Cie’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-81,312
Closed -$4.55M – 378
2023
Q4 		$4.55M Sell
81,312
-9,127
-10% -$397K 0.04% 159
2023
Q3 		$3.73M Sell
90,439
-4,237
-4% -$220K 0.04% 165
2023
Q2 		$5.29M Sell
94,676
-3,354
-3% -$182K 0.05% 161
2023
Q1 		$5.47M Sell
98,030
-7,192
-7% -$336K 0.05% 166
2022
Q4 		$3.83M Buy
105,222
+51,526
+96% +$1.68M 0.04% 206
2022
Q3 		$1.53M Sell
53,696
-4,721
-8% -$180K 0.02% 328
2022
Q2 		$2.64K Sell
58,417
-2,153
-4% -$112K 0.03% 259
2022
Q1 		$4.61M Sell
60,570
-5,553
-8% -$486K 0.04% 196
2021
Q4 		$9.85M Buy
66,123
+56,156
+563% +$8.6M 0.07% 133
2021
Q3 		$1.45M Buy
9,967
+1,144
+13% +$196K 0.02% 227
2021
Q2 		$1.73M Buy
8,823
+3,168
+56% +$573K 0.02% 213
2021
Q1 		$1.02M Buy
+5,655
New +$977K 0.01% 248

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Banque Pictet & Cie's TXG Position: Q1 2024 in Review

Banque Pictet & Cie sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 81,312 shares — an estimated $4.55M sold.

Banque Pictet & Cie first reported a position in TXG in Q1 2021 and held it in 12 quarters. The position peaked at $9.85M in Q4 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Banque Pictet & Cie reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Banque Pictet & Cie sold 81,312 10x Genomics shares in Q1 2024, an estimated $4.55M.
  • Banque Pictet & Cie first reported a position in 10x Genomics in Q1 2021 and held it in 12 quarters.
  • Banque Pictet & Cie's 10x Genomics position peaked at $9.85M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Banque Pictet & Cie's 13F filing for Q1 2024, filed 6 May 2024.